Brazil company requests emergency authorisation to use Covaxin
Last Updated IST
Representative Image. Credit: Reuters File Photo
Brazilian company Precisa Medicamentos, representing India's Bharat Biotech, on Monday, said it requested that the country's health regulator, Anvisa, grant emergency authorization to use the Covaxin Covid-19 vaccine.
In addition, it said Covaxin would be trialled in a Phase III study in Brazil carried out in partnership with Sao Paulo's Albert Einstein hospital.